DK385285A - Butyrolactamer, deres fremstilling og anvendelse - Google Patents

Butyrolactamer, deres fremstilling og anvendelse Download PDF

Info

Publication number
DK385285A
DK385285A DK385285A DK385285A DK385285A DK 385285 A DK385285 A DK 385285A DK 385285 A DK385285 A DK 385285A DK 385285 A DK385285 A DK 385285A DK 385285 A DK385285 A DK 385285A
Authority
DK
Denmark
Prior art keywords
butyrolactames
preparation
weeting
lensium
formulais
Prior art date
Application number
DK385285A
Other languages
English (en)
Other versions
DK385285D0 (da
Inventor
Chen Yan-Rong
Yang Ming-He
Huang Liang
Liu Geng-Tao
Ulrich Benz
Original Assignee
Chinese Acad Med Science
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese Acad Med Science, Bayer Ag filed Critical Chinese Acad Med Science
Publication of DK385285D0 publication Critical patent/DK385285D0/da
Publication of DK385285A publication Critical patent/DK385285A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Package Frames And Binding Bands (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK385285A 1984-08-24 1985-08-23 Butyrolactamer, deres fremstilling og anvendelse DK385285A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843431257 DE3431257A1 (de) 1984-08-24 1984-08-24 Neue (delta)-butyrolactame, pharmakologisch aktive zusammensetzungen derselben, verfahren zu ihrer herstellung und ihre medizinische verwendung

Publications (2)

Publication Number Publication Date
DK385285D0 DK385285D0 (da) 1985-08-23
DK385285A true DK385285A (da) 1986-02-25

Family

ID=6243847

Family Applications (1)

Application Number Title Priority Date Filing Date
DK385285A DK385285A (da) 1984-08-24 1985-08-23 Butyrolactamer, deres fremstilling og anvendelse

Country Status (16)

Country Link
US (1) US4879390A (da)
EP (1) EP0172514B1 (da)
JP (1) JPH0660159B2 (da)
KR (1) KR860001787A (da)
AT (1) ATE46504T1 (da)
AU (1) AU571729B2 (da)
CA (1) CA1262250A (da)
DE (2) DE3431257A1 (da)
DK (1) DK385285A (da)
ES (2) ES8609241A1 (da)
FI (1) FI853228L (da)
GR (1) GR852050B (da)
HU (1) HU195774B (da)
IL (1) IL76157A (da)
PT (1) PT81005B (da)
ZA (1) ZA856414B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU579029B2 (en) * 1985-10-18 1988-11-10 Bayer Aktiengesellschaft Process for the preparation of ` -butyrolactams
DE3616989A1 (de) * 1986-05-21 1987-11-26 Bayer Ag Enantiomerenreine 4,5-disubstituierte (gamma)-butyrolactame, verfahren zu ihrer herstellung und ihre verwendung
DE3927370A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate
DE3927367A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Verfahren zur herstellung von dehydrocycloclausenamid und dessen derivate in der racemischen form und als optisch aktive (+) oder (-)-enantiomere
JP4585073B2 (ja) * 2000-02-15 2010-11-24 丸善製薬株式会社 抗男性ホルモン剤、養毛化粧料、前立腺肥大抑制剤、外用剤及び飲食品
US6787564B2 (en) * 2002-03-26 2004-09-07 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use
EP1348696B1 (en) * 2002-03-26 2012-02-01 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Use of optically active clausenamides for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same
CN1295215C (zh) * 2002-12-31 2007-01-17 中国医学科学院药物研究所 黄皮酰胺的光学活性衍生物、其制法和其药物组合物与用途
WO2016015333A1 (en) * 2014-08-01 2016-02-04 F.Hoffmann-La Roche Ag 2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI325174A (da) * 1973-11-19 1975-05-20 Sandoz Ag

Also Published As

Publication number Publication date
FI853228A0 (fi) 1985-08-22
DK385285D0 (da) 1985-08-23
EP0172514B1 (en) 1989-09-20
ES8704457A1 (es) 1987-04-01
DE3573113D1 (en) 1989-10-26
ZA856414B (en) 1986-04-30
AU571729B2 (en) 1988-04-21
PT81005A (en) 1985-09-01
GR852050B (da) 1985-12-20
HU195774B (en) 1988-07-28
JPS62181250A (ja) 1987-08-08
ATE46504T1 (de) 1989-10-15
ES8609241A1 (es) 1986-07-16
DE3431257A1 (de) 1986-03-06
IL76157A (en) 1988-08-31
ES554061A0 (es) 1987-04-01
CA1262250A (en) 1989-10-10
FI853228L (fi) 1986-02-25
EP0172514A1 (en) 1986-02-26
AU4657185A (en) 1986-02-27
ES546381A0 (es) 1986-07-16
IL76157A0 (en) 1985-12-31
HUT38904A (en) 1986-07-28
PT81005B (en) 1987-06-26
JPH0660159B2 (ja) 1994-08-10
KR860001787A (ko) 1986-03-22
US4879390A (en) 1989-11-07

Similar Documents

Publication Publication Date Title
GB2124445B (en) Improvements in or relating to transimpedance amplifiers
EG19409A (en) Improvements relating to the processing of tobacco leaves.
DE2961735D1 (en) Improvements in or relating to audio teleconferencing
ES477587A1 (es) Un procedimiento para la preparacion de 1(p-metoxibenzoil)-2-pirrolidinona.
IL55801A0 (en) Novel proline derivatives and homologues thereof,their production and pharmaceutical compositions containing them
DK446684A (da) Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme
GB2080062B (en) Improvements in or relating to amplifiers
DK391485A (da) Ethylendiaminmonoamid-derivater, deres fremstilling og anvendelse
DK385285A (da) Butyrolactamer, deres fremstilling og anvendelse
GB2000456B (en) Improvements in or relating to clamping chucks
IT1066633B (it) Perfezionamento nei filtri pressa
HK53487A (en) Improvements in or relating to telephone sets
DK399985A (da) 6-substituerede mitomycin-analoge, deres anvendelse inden for medicinen og kompositioner indeholdende forbindelserne
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
DK111286A (da) Makroemulsioner, deres fremstilling og anvendelse til bekaempelse af skadelige organismer
ES2014448B3 (es) Composiciones protectoras para madera y proceso para su produccion.
IT8385632A0 (it) Pressa per produrre fiammiferi.
ZA855469B (en) Tetrahydrophthalimides,and their production and use
SG87188G (en) Improvements in or relating to tables
EP0148770A3 (en) Composition for cell cultivation, production and use thereof
DK510284A (da) 4-pentinsyre-derivater, deres fremstilling og anvendelse til bekaempelse af skadelige organismer
DE3569472D1 (en) Pharmaceutical composition, its production and use
SE8503118D0 (sv) Sett att tillverka sockerfri, alkoholhaltig punsch och rom
DK76484D0 (da) Salve til fjernelse af vorter
ZA783593B (en) Improvements in or relating to filtration,particularly biological filtration

Legal Events

Date Code Title Description
ATS Application withdrawn